Aug 2026· Medicinal Chemistry Research· Vol 35, pp. 1755 - 1773· 0 citations· 54 references
Medicine
TL;DR
The obtained findings demonstrated potential of 2-benzylaminothienopyrimidin-4(3H)-ones as promising scaffolds for further development of anticancer agents.
This study aims to synthesize a series of pyrimidine derivatives linked to active units and evaluate their anticancer and antioxidant activities. First, several Schiff bases were synthesized by the condensation of 2-aminopyrimidine- 4,6-diol with suitable aromatic aldehydes. Subsequently, Schiff bases were subjected to...
Q. A. Jaber· Indian Journal of Heterocycl...· 0 citations
Results suggest that the N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide scaffold is a useful template for designing selective BCR-ABL1-directed anticancer agents, with compound 9c as an encouraging lead for further optimisation and mechanistic studies.
Pradeep B. Bhise, Sandeep B. Bhise, Somnath Dasgupta et al.· RSC Advances· 0 citations
Findings indicate that the benzimidazole-1,3,4-oxadiazole hybrid scaffold may provide a useful starting point for the development of breast cancer-oriented antiproliferative candidates.
Mahmut Gozelle, Şevval Yaman, Züleyha Arslan et al.· Fabad journal of pharmaceuti...· 0 citations
The results demonstrated that the DFT-optimized molecular structure is in good agreement with the crystal structure measured by X-ray single-crystal diffraction, thereby validating the reliability of the theoretical calculations.
Wei Zeng, Run-Tao Guo, Lan Jin et al.· Russian journal of general c...· 0 citations
Pyrimidine and furo[2,3-d]pyrimidine derivatives have emerged as promising anticancer agents that act through multiple mechanisms, including modulation of downstream signaling pathways such as a JAK2/STAT3 cascade. Herein, we report the synthesis of novel pyrimidine- and furo[2,3-d]pyrimidine-isoxazole hybrids via base...
Martina Piškor Benković, I. Ćorić, Leo Sačer et al.· RSC Medicinal Chemistry· 0 citations
The synthesis of a series of novel 2,5-di(aryl/heteroaryl)-1,3,4-oxadiazole derivatives using molecular iodine under basic conditions identifies 9b and 9g as promising lead 1,3,4-oxadiazole derivatives for further development as anticancer agents.
Thongolla Ramesha, T. Shenoy, U. V. Subba Reddy et al.· RSC Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.